Hookipa Pharma Inc
HOOK
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.27M
Close$
$3.10
169.1% upside
Current Fair Value
169.1% upsideUndervalued by 169.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.27 Million |
|---|---|
| Enterprise Value | $-19,413,398.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.09 |
| Beta | 0.83 |
| Outstanding Shares | 12,682,805 |
Return
| Return on Equity | -195.24% |
|---|---|
| Return on Assets | -106.26% |
| Return on Invested Capital | -160.21% |
Valuation & Multiples
| P/E Ratio | -0.34 |
|---|---|
| PEG | 0.38 |
| Price to Sales | - |
| Price to Book Ratio | 0.58 |
| Enterprise Value to Revenue | -2.38 |
| Enterprise Value to EBIT | 0.31 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.14%▼ 31.06% |
|---|---|
| Total Invested | $363,143▼ 93.25% |
| Investors Holding | 4▼ 22.00% |
ESG Score
No data